ArticleJournal of inflammation research2026
Comparative Effectiveness and Safety of Risankizumab vs Ustekinumab in Crohn's Disease: A Real-World Retrospective Cohort Study from Taiwan.
Ming-Jung Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.